Company
Overview
Our Commitment
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase I – IIa)
Phase I-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Global Clinical Development (Phase II-IV)
Development and Regulatory Services
Feasibility Research
Investigator and Patient Recruitment
Project Management and Clinical Monitoring
Medical Affairs and Safety Management
Central Lab & Centralized Cardiac Services
Data Management
Biostatistics
Medical and Scientific Writing
Quality Assurance
Connecting your trials to global regions
Bioanalysis
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
Therapeutic Experience
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Global Clinical Development (Phase II-IV)
Bioanalysis
Global Central Lab
Scientific Library
Posters
Presentations
Podcasts
Webinars
Case Studies
White Papers
Events
News
News Releases
Media Coverage
Contact Us
Study Participation
Medical Investigators
Careers at MDS
Investors
MDS Pharma Services News
April 8, 2009
MDS Pharma Services Appoints Dr. Ping Li as Laboratory Director for Beijing Central Lab
March 11, 2009
MDS Pharma Services Scientist Named to List of ‘Notable People in R&D’ for 2009
February 12, 2009
MDS Pharma Services Scientist to Discuss Development of Biosimilar Monoclonal Antibodies at EGA Symposium
More news from MDS Inc.
Home
/
Services
/
Global Central Lab
/
Centralized Cardiac Services
/
ECG Locations
ECG Locations
Three strategic locations provide dedicated, multi-lingual project management, data management and site support
MDS Pharma Services has ECG reception sites in Paris, Toronto and Singapore. Call center staff are trained on equipment and protocol-specific requirements to enable the highest level of site support worldwide. The company has the largest number of phase I beds globally, more than 900, and offers 12-Lead ECG and Holter at all phase I units. In combination with its central laboratory facilities in Toronto, Paris, Hamburg, Singapore, Beijing and affiliates in Argentina, Brazil, Mexico, South Africa and Australia, MDS Pharma Services can support clinical studies through phase IIb-IV.
Please
click here
for locations.
Global Central Lab
Global Services
Project and Data Management
Remote Data Access
Global Distribution and Logistics
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
APOLLO CLPM
News
MDS Pharma Services Adopts Leading-Edge ECG Technology, September 2006
MDS Pharma Services Earns Mortara Certification, September 2006
Contact MDS Pharma Services Centralized Cardiac Services:
North America:
1-800-465-5837, ext. 2737
Europe:
+44-1324-563887
Asia:
+65-6896-5300
or fill out an
Online Request
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map